Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09CIF
|
|||
Former ID |
DNCL002511
|
|||
Drug Name |
TH-9402
|
|||
Synonyms |
174230-05-8; ATIR
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Graft-versus-host disease [ICD-11: 4B24; ICD-9: 279.5] | Phase 2 | [1] | |
Company |
Kiadis Pharma
|
|||
Structure |
Download2D MOL
|
|||
Formula |
C21H15Br2ClN2O3
|
|||
Canonical SMILES |
COC(=O)C1=CC=CC=C1C2=C3C=CC(=[NH2+])C(=C3OC4=C2C=CC(=C4Br)N)Br.[Cl-]
|
|||
InChI |
1S/C21H14Br2N2O3.ClH/c1-27-21(26)11-5-3-2-4-10(11)16-12-6-8-14(24)17(22)19(12)28-20-13(16)7-9-15(25)18(20)23;/h2-9,24H,25H2,1H3;1H
|
|||
InChIKey |
MUDCDMMNYVJLEB-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT02519816) Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.